News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
GPC Biotech AG Patents Satraplatin Drug in Europe
June 12, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Bloomberg -- GPC Biotech AG, the German biotech company whose shares have fallen 86 percent in the past 12 months, was granted a European patent for its Satraplatin cancer treatment.
Twitter
LinkedIn
Facebook
Email
Print
Europe
MORE ON THIS TOPIC
Europe
With Tariffs Looming, EU and US Pharmas Make Demands of European Commission
April 16, 2025
·
2 min read
·
Tristan Manalac
Layoffs
The 5 Largest Biopharma Layoffs of Q1 2025
April 10, 2025
·
5 min read
·
Angela Gabriel
Duchenne muscular dystrophy
Committee Recommends EU Trials of Sarepta’s Elevidys Continue, Day After Holds
April 4, 2025
·
2 min read
·
Dan Samorodnitsky
Alzheimer’s disease
EU Rejects Lilly’s Alzheimer’s Drug Kisunla, Following Same Path as Rival Leqembi
March 28, 2025
·
2 min read
·
Dan Samorodnitsky
